Skip to main navigation
Skip to search
Skip to main content
Macquarie University Home
Help & FAQ
Home
Profiles
Research units
Projects
Research Outputs
Datasets
Prizes
Activities
Press/Media
Impacts
Search by expertise, name or affiliation
Improving Sunitinib Efficacy and tolerability in patients with metastatic clear cell carcinoma of the kidney by using a 14/7 day schedule and ToxicityAdjusted Dosing (ISE TAD147)
Gurney, Howard
(Primary Chief Investigator)
Project
:
Research
Overview
Fingerprint
Project Details
Status
Finished
Effective start/end date
1/07/15
→
1/07/17
View all
View less